Stereotaxis (STXS) Income towards Parent Company (2010 - 2026)
Stereotaxis' (STXS) quarterly Income towards Parent Company came in at -$12.8 million in Q1 2026, down 105.34% year-on-year from $239.5 million in Q1 2025, and down 83.49% on a QoQ basis from -$7.0 million in Q4 2025.
Stereotaxis (STXS) Income towards Parent Company (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Income towards Parent Company data on file, last reported at -$12.8 million in Q1 2026.
- On a quarterly basis, Income towards Parent Company fell 105.34% year-over-year to -$12.8 million in Q1 2026; TTM through Mar 2026 was -$32.5 million, a 16.93% decrease from a year earlier, with the FY2025 full-year figure at -$24.3 million, up 61.77% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$12.8 million, down from -$7.0 million in the prior quarter.
- Over the last five years, Income towards Parent Company for STXS reached as high as -$4.5 million in Q1 2022 and fell as low as -$12.8 million in Q1 2026.
- Historically, Income towards Parent Company has averaged -$6.4 million across 5 years, with a median of -$5.9 million in 2023.
- Across the five-year window, Income towards Parent Company slumped 109.5% in 2022 and gained 19.3% in 2025, its largest moves.
- Year by year, Income towards Parent Company stood at -$4.7 million in 2022, then retreated by 18.46% to -$5.6 million in 2023, then slumped by 55.13% to -$8.6 million in 2024, then grew by 19.3% to -$7.0 million in 2025, then plunged by 83.49% to -$12.8 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$12.8 million in Q1 2026, -$7.0 million in Q4 2025, and -$6.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Stereotaxis | 128.56 Mn | 113.94 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.78 Mn |
| Dec 31, 2025 | -6.96 Mn |
| Sep 30, 2025 | -6.86 Mn |
| Jun 30, 2025 | -5.86 Mn |
| Mar 31, 2025 | -6.22 Mn |
| Dec 31, 2024 | -8.63 Mn |
| Sep 30, 2024 | -6.63 Mn |
| Jun 30, 2024 | -6.27 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | -5.56 Mn |
| Sep 30, 2023 | -5.89 Mn |
| Jun 30, 2023 | -5.52 Mn |
| Mar 31, 2023 | -5.86 Mn |
| Dec 31, 2022 | -4.70 Mn |
| Sep 30, 2022 | -5.28 Mn |
| Jun 30, 2022 | -5.40 Mn |
| Mar 31, 2022 | -4.52 Mn |
| Dec 31, 2021 | -3.78 Mn |
| Sep 30, 2021 | -5.24 Mn |
| Jun 30, 2021 | -3.93 Mn |